Dr. Erasmo A. Passaro, MD

Dr. Passaro practices at Florida Center for Neurology, Inc in Saint Petersburg, Florida.

Dr. Passaro's NPI, 1972599439, was assigned on September 21, 2005. Dr. Passaro graduated from Rutgers Robert Wood Johnson Medical School in 1988. Dr. Passaro holds Florida license ME67462.

Dr. Passaro's primary practice is Florida Center for Neurology, Inc, at 1607 Martin Luther King Jr N St, Saint Petersburg, FL 33704 in Pinellas County. The practice phone is (727) 329-8833.

Dr. Passaro's primary practice is Florida Center for Neurology, Inc in Saint Petersburg, Florida. Dr. Passaro is also affiliated with Orlando Health Bayfront Hospital. The medical group on file is Florida Center for Neurology. Dmand AI also links Dr. Passaro to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Passaro practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Passaro's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Passaro is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Passaro's licenses on file in 3 states: Florida, Michigan and California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Passaro treats.

CMS data shows 2,824 Medicare services from Dr. Passaro across 25 procedure codes in 2024, for 496 Medicare patients. Medicare paid $283,661 for them.

CMS counts 496 Medicare patients who saw Dr. Passaro in 2024. The largest group is 65 to 74, with 206 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Passaro's median patient age at 59, with 48% women.

In 2024, Dr. Passaro wrote 3,770 Medicare Part D claims for 524 patients. 80% of them were for generic drugs. CMS names the drug for 3,370 of them, across 54 drugs with 11 or more claims each, at $1,151,133 in total drug cost. In 2023, CMS named 2,469 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Passaro for performance year 2024, reported as part of a group. Dr. Passaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Passaro as offering telehealth.

Dmand AI links 11 papers to Dr. Passaro. The most frequent topics are Electroencephalography, Epilepsy and Brain. Dr. Passaro has published most often in J Clin Neurophysiol. Dr. Passaro's most frequent co-authors are Konstantin Volod Elisevich, MD, Carl W. Bazil, MD, PhD and Selim Ramin Benbadis, MD.

CMS Open Payments shows 1,040 general payments to Dr. Passaro from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. UCB, Inc. paid the most, $214,202.

Dmand AI lists 5 awards for Dr. Passaro, most recently Best Doctors in 2020. Dr. Passaro serves on Board of Directors American Society of Neuroimaging, Board of Directors Bayfront Health System and CME committee ACNS.

Dr. Passaro graduated from Rutgers Robert Wood Johnson Medical School in 1988. Dr. Passaro is a member of AAN, AASM, AES and AMA.

Dr. Passaro is in network with 8 carriers, including Aetna, United Healthcare and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.